Quantitation with chemical tagging reagents in biomarker studies

scientific article

Quantitation with chemical tagging reagents in biomarker studies is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1002/PRCA.201400120
P698PubMed publication ID25504339
P5875ResearchGate publication ID269520662

P50authorPhillip C. WrightQ30505784
P2093author name stringJules A Westbrook
Josselin Noirel
Janet E Brown
Caroline A Evans
P2860cites workMultiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagentsQ29547450
Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studiesQ33688759
Susceptibility to COPD: differential proteomic profiling after acute smokingQ33921450
Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variabilityQ34149563
Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MSQ34192662
Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directionsQ34279143
iTRAQ underestimation in simple and complex mixtures: "the good, the bad and the ugly".Q35002931
Gas-phase purification enables accurate, multiplexed proteome quantification with isobaric taggingQ35488768
MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomicsQ35491186
Statistical considerations of optimal study design for human plasma proteomics and biomarker discoveryQ35873957
Protein biomarker discovery and validation: the long and uncertain path to clinical utilityQ36561644
Design and analysis issues in quantitative proteomics studiesQ36950957
Review of software tools for design and analysis of large scale MRM proteomic datasetsQ37177456
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker developmentQ37714579
Banking of clinical samples for proteomic biomarker studies: a consideration of logistical issues with a focus on pre-analytical variationQ37817290
An insight into iTRAQ: where do we stand now?Q37997372
Isobaric tagging approaches in quantitative proteomics: the ups and downsQ38009633
Opportunities for protein interaction network-guided cellular engineeringQ38071034
Label-free quantification in clinical proteomicsQ38097312
Comparison of label-free and label-based strategies for proteome analysis of hepatoma cell lines.Q39108916
A critical assessment of feature selection methods for biomarker discovery in clinical proteomicsQ41894005
Addressing accuracy and precision issues in iTRAQ quantitationQ42427843
Western blots versus selected reaction monitoring assays: time to turn the tables?Q42595907
Candidate verification of iron-regulated Neisseria meningitidis proteins using isotopic versions of tandem mass tags (TMT) and single reaction monitoringQ42634780
Statistical inference from multiple iTRAQ experiments without using common reference standardsQ42984757
Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissuesQ46481136
iTRAQ experimental design for plasma biomarker discoveryQ47639363
Hyperplex-MRM: a hybrid multiple reaction monitoring method using mTRAQ/iTRAQ labeling for multiplex absolute quantification of human colorectal cancer biomarkerQ47874059
Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ).Q51075678
General statistical framework for quantitative proteomics by stable isotope labeling.Q51113887
Systematic comparison of label-free, metabolic labeling, and isobaric chemical labeling for quantitative proteomics on LTQ Orbitrap Velos.Q51467338
Comparative analysis to guide quality improvements in proteomics.Q51772108
Proteomics meets the scientific method.Q55056925
Report from the Wellcome Trust/EBA “Perspectives in Clinical Proteomics” retreat - A strategy to implement Next-Generation Proteomic Analyses to the clinic for patient benefit: Pathway to translationQ56444472
P433issue3-4
P921main subjectbiomarkerQ864574
P304page(s)295-300
P577publication date2015-02-10
P1433published inProteomics - Clinical ApplicationsQ15754475
P1476titleQuantitation with chemical tagging reagents in biomarker studies
P478volume9

Reverse relations

cites work (P2860)
Q47421750Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling
Q61816784Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives
Q26774743Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology
Q55293538Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease.
Q52725521Designing Successful Proteomics Experiments.
Q57821720Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis
Q57058181Mass spectrometry-based proteomics techniques and their application in ovarian cancer research
Q52687355Novel proteins that regulate cell extension formation in fibroblasts.
Q58779295Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias
Q47729926Proteomic analysis of mitochondria: biological and clinical progresses in cancer
Q52662413Proteomic analysis of plasma from rheumatoid arthritis patients with mild cognitive impairment.
Q92510792Proteomics and Bioinformatics Analysis of Cartilage in Post-Traumatic Osteoarthritis in a Mini-Pig Model of Anterior Cruciate Ligament Repair
Q50984144Science is 1% inspiration and 99% biomarkers.
Q38447411Spermatogenesis-associated proteins at different developmental stages of buffalo testicular seminiferous tubules identified by comparative proteomic analysis
Q38785881Taking the stock of granule cargo: Platelet releasate proteomics

Search more.